![Dmitriy Genkin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dmitriy Genkin
Président chez
PHARMSYNTHEZ
Fortune : 199 230 $ au 30/06/2026
Profil
Dr. Dmitriy D.
Genkin, MD, is an Executive Chairman at Pharmsynthez PJSC, a Managing Director at FDS Pharma LLP and a Director & Partner at FDS Pharma Associates Ltd. He is on the Board of Directors at Kevelt AS, SynBio LLC, EPhaG AS, CLS Therapeutics, Inc., Peri-Ness Technologies Ltd., Santersus AG, FDS Pharma Associates Ltd. and Xenetic Biosciences, Inc. Dr. Genkin was previously employed as a Non-Executive Director by Xenetic Biosciences, Inc., a Non-Executive Director by Human Stem Cells Institute OJSC, a Non-Executive Director by Xenetic Biosciences, Inc., and a Professor by University College London.
He also served on the board at Xenetic Biosciences Plc.
He received his undergraduate degree from Mechnikov St Petersburg State Medical Academy and a graduate degree from The School of Pharmacy University of London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/10/2025 | 68 464 ( 2,99% ) | 199 230 $ | 30/06/2026 |
Postes actifs de Dmitriy Genkin
| Sociétés | Poste | Début |
|---|---|---|
| PHARMSYNTHEZ | Président | 01/01/2005 |
| XENETIC BIOSCIENCES, INC. | Directeur/Membre du Conseil | - |
Peri-Ness Technologies Ltd.
 Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focusing on addressing the problems of male fertility | Directeur/Membre du Conseil | - |
SANTERSUS AG
 SANTERSUS AG Medical SpecialtiesHealth Technology Develops novel patent protected transformative, lifesaving and blood purification devices | Fondateur | - |
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/01/2011 |
Kevelt AS
 Kevelt AS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur/Membre du Conseil | 01/01/2013 |
FDS Pharma LLP
 FDS Pharma LLP Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/01/2003 |
EPhaG AS
 EPhaG AS Drugstore ChainsRetail Trade Operates as a holding company for pharmacies | Directeur/Membre du Conseil | 01/01/2007 |
FDS Pharma Associates Ltd. | Directeur/Membre du Conseil | 17/11/2010 |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Dmitriy Genkin
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Dmitriy Genkin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
FDS Pharma Associates Ltd. | |
EPhaG AS
EPhaG AS Drugstore ChainsRetail Trade Operates as a holding company for pharmacies | Retail Trade |
Pharmsynthez PJSC
 Pharmsynthez PJSC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Artgen Biotech PJSC
 Artgen Biotech PJSC Medical/Nursing ServicesHealth Services Provides genetic testing & research, COVID-19 testing, reproductive medicine and regenerative medicine services | Health Services |
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focusing on addressing the problems of male fertility | Health Technology |
Kevelt AS
Kevelt AS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
FDS Pharma LLP
FDS Pharma LLP Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Mechnikov St Petersburg State Medical Academy
 Mechnikov St Petersburg State Medical Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenetic Biosciences, Inc.
 Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
The School of Pharmacy University of London
 The School of Pharmacy University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CLS THERAPEUTICS, INC.
 CLS THERAPEUTICS, INC. Pharmaceuticals: MajorHealth Technology CLS Therapeutics, Inc. is a biopharmaceutical company specializing in anticancer gene therapies targeting circulating cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs), which contribute to tumor progression and therapy resistance. The company is based in New York, NY. The company's lead candidate, CLS-014, is an adeno-associated viral vector delivering a recombinant human DNase I enzyme to the liver, enabling hepatocytes to degrade harmful cfDNA in the bloodstream and tumor microenvironment. This approach aims to inhibit tumor growth and metastasis, with an initial focus on advanced pancreatic cancer. | Health Technology |
SANTERSUS AG
SANTERSUS AG Medical SpecialtiesHealth Technology Develops novel patent protected transformative, lifesaving and blood purification devices | Health Technology |
